Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - axitinib, quantity: 7 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; iron oxide red - for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - axitinib, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; iron oxide red - for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - axitinib, quantity: 3 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; triacetin; iron oxide red - for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - axitinib, quantity: 5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; lactose monohydrate; titanium dioxide; hypromellose; triacetin; iron oxide red - for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - axitinib, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; iron oxide red - for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - film-coated tablet - axitinib 1 mg - antineoplastic agents

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - film-coated tablet - axitinib 3 mg - antineoplastic agents

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - film-coated tablet - axitinib 5 mg - antineoplastic agents

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - film-coated tablet - axitinib 7 mg - antineoplastic agents

Kenya - English - Pharmacy and Poisons Board

axitinib - tablet - axitinib inn 5mg - axitinib